

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 8.18472069 |
| 2 | negative regulation of macroautophagy (GO:0016242) | 7.90401219 |
| 3 | regulation of autophagic vacuole assembly (GO:2000785) | 7.26061767 |
| 4 | intestinal absorption (GO:0050892) | 7.17474575 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 6.84824217 |
| 6 | cytidine deamination (GO:0009972) | 6.75596713 |
| 7 | cytidine metabolic process (GO:0046087) | 6.75596713 |
| 8 | cytidine catabolic process (GO:0006216) | 6.75596713 |
| 9 | sulfate transmembrane transport (GO:1902358) | 6.39859136 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.29202823 |
| 11 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.98682360 |
| 12 | angiotensin maturation (GO:0002003) | 5.94538896 |
| 13 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.91244714 |
| 14 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.91244714 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.83073734 |
| 16 | regulation of vacuole organization (GO:0044088) | 5.82385481 |
| 17 | negative regulation of T cell differentiation in thymus (GO:0033085) | 5.80186168 |
| 18 | negative regulation of organelle assembly (GO:1902116) | 5.74155892 |
| 19 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 5.62391850 |
| 20 | positive regulation of T cell differentiation in thymus (GO:0033089) | 5.57142193 |
| 21 | regulation of viral release from host cell (GO:1902186) | 5.51325482 |
| 22 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.47095562 |
| 23 | sulfate transport (GO:0008272) | 5.25572056 |
| 24 | bile acid and bile salt transport (GO:0015721) | 5.14005360 |
| 25 | regulation of platelet aggregation (GO:0090330) | 5.09098497 |
| 26 | keratinocyte development (GO:0003334) | 5.00966203 |
| 27 | negative regulation of norepinephrine secretion (GO:0010700) | 4.99772602 |
| 28 | regulation of platelet activation (GO:0010543) | 4.98136914 |
| 29 | adenosine receptor signaling pathway (GO:0001973) | 4.92407571 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.88054182 |
| 31 | hemidesmosome assembly (GO:0031581) | 4.85826871 |
| 32 | low-density lipoprotein particle remodeling (GO:0034374) | 4.81906403 |
| 33 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.80418443 |
| 34 | chondrocyte proliferation (GO:0035988) | 4.77676949 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 4.64996239 |
| 36 | actin filament depolymerization (GO:0030042) | 4.55747054 |
| 37 | intestinal epithelial cell development (GO:0060576) | 4.55367371 |
| 38 | blood coagulation, intrinsic pathway (GO:0007597) | 4.51470417 |
| 39 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.41081703 |
| 40 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.40206422 |
| 41 | platelet aggregation (GO:0070527) | 4.38149244 |
| 42 | alkaloid metabolic process (GO:0009820) | 4.38068732 |
| 43 | regulation of lipoprotein metabolic process (GO:0050746) | 4.36827316 |
| 44 | response to hepatocyte growth factor (GO:0035728) | 4.35250889 |
| 45 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.35250889 |
| 46 | sulfur compound transport (GO:0072348) | 4.34988859 |
| 47 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.32642118 |
| 48 | regulation of integrin activation (GO:0033623) | 4.32237391 |
| 49 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.28263144 |
| 50 | negative regulation of platelet activation (GO:0010544) | 4.23079878 |
| 51 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.22976620 |
| 52 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.21877782 |
| 53 | epithelial structure maintenance (GO:0010669) | 4.18551463 |
| 54 | vitamin A metabolic process (GO:0006776) | 4.16723629 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 4.08561981 |
| 56 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.08484630 |
| 57 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.08224943 |
| 58 | thyroid hormone metabolic process (GO:0042403) | 4.04866240 |
| 59 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.97530421 |
| 60 | epithelial cell-cell adhesion (GO:0090136) | 3.95682440 |
| 61 | virion attachment to host cell (GO:0019062) | 3.92651989 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 3.92651989 |
| 63 | lipoxygenase pathway (GO:0019372) | 3.90624762 |
| 64 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.86914160 |
| 65 | digestive system process (GO:0022600) | 3.85590983 |
| 66 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.82509484 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81627109 |
| 68 | neutrophil activation (GO:0042119) | 3.80614435 |
| 69 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.78622284 |
| 70 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.76192513 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.74214614 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 3.71237281 |
| 73 | O-glycan processing (GO:0016266) | 3.70746408 |
| 74 | beta-amyloid metabolic process (GO:0050435) | 3.68034026 |
| 75 | nucleotide salvage (GO:0043173) | 3.67276240 |
| 76 | hydrogen peroxide catabolic process (GO:0042744) | 3.64923722 |
| 77 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.63504427 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 3.61888400 |
| 79 | modified amino acid transport (GO:0072337) | 3.61278057 |
| 80 | negative regulation of heart rate (GO:0010459) | 3.59989454 |
| 81 | cGMP-mediated signaling (GO:0019934) | 3.58362691 |
| 82 | angiogenesis involved in wound healing (GO:0060055) | 3.58212401 |
| 83 | platelet degranulation (GO:0002576) | 3.57268353 |
| 84 | high-density lipoprotein particle remodeling (GO:0034375) | 3.55664142 |
| 85 | cyclooxygenase pathway (GO:0019371) | 3.53805537 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 3.53438952 |
| 87 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.52305205 |
| 88 | antibacterial humoral response (GO:0019731) | 3.52174606 |
| 89 | regulation of keratinocyte proliferation (GO:0010837) | 3.51850385 |
| 90 | sulfur amino acid catabolic process (GO:0000098) | 3.51120133 |
| 91 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.49699624 |
| 92 | peptide catabolic process (GO:0043171) | 3.49554124 |
| 93 | drug catabolic process (GO:0042737) | 3.47775755 |
| 94 | antimicrobial humoral response (GO:0019730) | 3.46492065 |
| 95 | positive regulation of epidermis development (GO:0045684) | 3.45288333 |
| 96 | regulation of water loss via skin (GO:0033561) | 3.43120367 |
| 97 | hydrogen peroxide metabolic process (GO:0042743) | 3.39770907 |
| 98 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.39610938 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.38161097 |
| 100 | bone resorption (GO:0045453) | 3.37078216 |
| 101 | transcytosis (GO:0045056) | 3.36286080 |
| 102 | estrogen biosynthetic process (GO:0006703) | 3.36114727 |
| 103 | regulation of guanylate cyclase activity (GO:0031282) | 3.35788364 |
| 104 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.34774381 |
| 105 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.34654316 |
| 106 | response to hydroperoxide (GO:0033194) | 3.33982510 |
| 107 | granulocyte activation (GO:0036230) | 3.31649013 |
| 108 | megakaryocyte development (GO:0035855) | 3.31052182 |
| 109 | somite development (GO:0061053) | 3.31028378 |
| 110 | reverse cholesterol transport (GO:0043691) | 3.30185035 |
| 111 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.29342391 |
| 112 | hepatocyte apoptotic process (GO:0097284) | 3.28260928 |
| 113 | negative regulation of receptor activity (GO:2000272) | 3.25334189 |
| 114 | platelet activation (GO:0030168) | 3.24037740 |
| 115 | positive regulation of hemostasis (GO:1900048) | 3.23287622 |
| 116 | positive regulation of blood coagulation (GO:0030194) | 3.23287622 |
| 117 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.20740339 |
| 118 | homotypic cell-cell adhesion (GO:0034109) | 3.20228268 |
| 119 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.19470887 |
| 120 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.18084764 |
| 121 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17854831 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17854831 |
| 123 | establishment of skin barrier (GO:0061436) | 3.16390970 |
| 124 | platelet formation (GO:0030220) | 3.15737191 |
| 125 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.14992908 |
| 126 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.14990728 |
| 127 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.13587203 |
| 128 | regulation of regulatory T cell differentiation (GO:0045589) | 3.11894224 |
| 129 | adhesion of symbiont to host (GO:0044406) | 3.11849833 |
| 130 | positive regulation of macrophage differentiation (GO:0045651) | 3.11845052 |
| 131 | phospholipid homeostasis (GO:0055091) | 3.11312929 |
| 132 | regulation of norepinephrine secretion (GO:0014061) | 3.11202814 |
| 133 | glucose 6-phosphate metabolic process (GO:0051156) | 3.09520050 |
| 134 | negative regulation of heart contraction (GO:0045822) | 3.08436936 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.08119776 |
| 136 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.07577972 |
| 137 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.06704746 |
| 138 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.05435974 |
| 139 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.05435974 |
| 140 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.05435974 |
| 141 | regulation of female receptivity (GO:0045924) | 3.02894550 |
| 142 | fucose catabolic process (GO:0019317) | 3.02549736 |
| 143 | L-fucose metabolic process (GO:0042354) | 3.02549736 |
| 144 | L-fucose catabolic process (GO:0042355) | 3.02549736 |
| 145 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.02407826 |
| 146 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02394132 |
| 147 | negative regulation of appetite (GO:0032099) | 3.02261566 |
| 148 | negative regulation of response to food (GO:0032096) | 3.02261566 |
| 149 | negative regulation of catecholamine secretion (GO:0033604) | 3.01556058 |
| 150 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.98163166 |
| 151 | regulation of blood coagulation (GO:0030193) | 2.97830743 |
| 152 | regulation of hemostasis (GO:1900046) | 2.97830743 |
| 153 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.96198141 |
| 154 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.96198141 |
| 155 | positive regulation of coagulation (GO:0050820) | 2.94886957 |
| 156 | regulation of receptor recycling (GO:0001919) | 2.93544665 |
| 157 | purine nucleotide salvage (GO:0032261) | 2.93115991 |
| 158 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.92932403 |
| 159 | neurotransmitter biosynthetic process (GO:0042136) | 2.92486027 |
| 160 | endothelium development (GO:0003158) | 2.91999959 |
| 161 | vitamin transmembrane transport (GO:0035461) | 2.91804218 |
| 162 | thyroid hormone generation (GO:0006590) | 2.91697157 |
| 163 | phospholipid efflux (GO:0033700) | 2.90866842 |
| 164 | purinergic receptor signaling pathway (GO:0035587) | 2.90803380 |
| 165 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.90169083 |
| 166 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.89077456 |
| 167 | autophagic vacuole fusion (GO:0000046) | 2.88364920 |
| 168 | innate immune response in mucosa (GO:0002227) | 2.88361891 |
| 169 | cholesterol homeostasis (GO:0042632) | 2.88251183 |
| 170 | extracellular fibril organization (GO:0043206) | 2.87789838 |
| 171 | sterol homeostasis (GO:0055092) | 2.86961233 |
| 172 | regulation of T cell differentiation in thymus (GO:0033081) | 2.86403652 |
| 173 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85585859 |
| 174 | regulation of endothelial cell differentiation (GO:0045601) | 2.85142919 |
| 175 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.83345425 |
| 176 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81823455 |
| 177 | dendritic cell chemotaxis (GO:0002407) | 2.81651830 |
| 178 | negative regulation of blood coagulation (GO:0030195) | 2.78483642 |
| 179 | negative regulation of hemostasis (GO:1900047) | 2.78483642 |
| 180 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.77816130 |
| 181 | regulation of coagulation (GO:0050818) | 2.73146005 |
| 182 | mitochondrial calcium ion transport (GO:0006851) | 2.72737928 |
| 183 | fatty acid elongation (GO:0030497) | 2.71935344 |
| 184 | female mating behavior (GO:0060180) | 2.71834331 |
| 185 | fibril organization (GO:0097435) | 2.70308813 |
| 186 | vesicle targeting (GO:0006903) | 2.68892882 |
| 187 | * protein neddylation (GO:0045116) | 2.68892663 |
| 188 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.68583949 |
| 189 | regulation of memory T cell differentiation (GO:0043380) | 2.67848967 |
| 190 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.66992782 |
| 191 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.65637255 |
| 192 | androgen biosynthetic process (GO:0006702) | 2.61655682 |
| 193 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61342471 |
| 194 | polyamine biosynthetic process (GO:0006596) | 2.60926169 |
| 195 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.59117641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.44780535 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.04955961 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.49603947 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.25033400 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.99248423 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.93354011 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.73971533 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.71670939 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65351475 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64231473 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49737425 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.48394324 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.47402228 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.44794537 |
| 15 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.42680493 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38407692 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33472915 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.29741402 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25455523 |
| 20 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.21518816 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.15020751 |
| 22 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14332007 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.12905542 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.07465023 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.07359228 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02452899 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01957812 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.01201846 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01060522 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.3444472 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98500421 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97916157 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.94393296 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93394222 |
| 35 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.92312327 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91928362 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86777800 |
| 38 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.86034182 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85330015 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77570939 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.77419218 |
| 42 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.71911266 |
| 43 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.71303450 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71026184 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68827170 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67863432 |
| 47 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.65965844 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65143430 |
| 49 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.63819575 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.63780403 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63758347 |
| 52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63741050 |
| 53 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.57168930 |
| 54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.57080551 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56957505 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52581093 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48232190 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48024112 |
| 59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46731809 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44809982 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43994815 |
| 62 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41971395 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40483386 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40077309 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39596859 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38471366 |
| 67 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.37960667 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35887712 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35378679 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.32549325 |
| 71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31843279 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31642533 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30455999 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30332718 |
| 75 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30277163 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29762676 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28710366 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27862336 |
| 79 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23850702 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23422496 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23263989 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22034958 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21125268 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21125268 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20556072 |
| 86 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20023219 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19493041 |
| 88 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18589385 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17722018 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15511749 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14810050 |
| 92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14736473 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14736473 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14066585 |
| 95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13640091 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12713903 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12634930 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11669759 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11650792 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11412834 |
| 101 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.11077599 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11025406 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10213488 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09900055 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08851365 |
| 106 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.08199152 |
| 107 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05672650 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04848857 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03971296 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03505498 |
| 111 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03229508 |
| 112 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01404366 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00339493 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99892261 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99453016 |
| 116 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99291199 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98096554 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94241406 |
| 119 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93125812 |
| 120 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92528438 |
| 121 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92115146 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91771519 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90085893 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89680042 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88619632 |
| 126 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87857821 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86997042 |
| 128 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86963496 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.86569465 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86030050 |
| 131 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85742331 |
| 132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85279398 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85190735 |
| 134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.84466237 |
| 135 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.84009168 |
| 136 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83470950 |
| 137 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82716280 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81922177 |
| 139 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81740502 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81725965 |
| 141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81719654 |
| 142 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.81688802 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81549324 |
| 144 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81152126 |
| 145 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.80478177 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80289561 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80185455 |
| 148 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79979383 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79578055 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79114025 |
| 151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78557931 |
| 152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.78310979 |
| 153 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.77841819 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77385128 |
| 155 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76770783 |
| 156 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.76382987 |
| 157 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76223119 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76101217 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.72402304 |
| 160 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71304290 |
| 161 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.70032142 |
| 162 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.69892747 |
| 163 | P68_20966046_ChIP-Seq_HELA_Human | 0.69607523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 8.50046844 |
| 2 | MP0005464_abnormal_platelet_physiology | 8.18224195 |
| 3 | MP0003283_abnormal_digestive_organ | 6.60423216 |
| 4 | MP0005360_urolithiasis | 5.70271297 |
| 5 | MP0008004_abnormal_stomach_pH | 4.61807182 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.50742168 |
| 7 | MP0000462_abnormal_digestive_system | 4.09432103 |
| 8 | MP0003724_increased_susceptibility_to | 3.97962633 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 3.59424769 |
| 10 | MP0003315_abnormal_perineum_morphology | 3.25054542 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 3.12947234 |
| 12 | MP0009053_abnormal_anal_canal | 2.91530186 |
| 13 | MP0002234_abnormal_pharynx_morphology | 2.76545399 |
| 14 | MP0003866_abnormal_defecation | 2.75609717 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.64125989 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.60330986 |
| 17 | MP0004510_myositis | 2.48800659 |
| 18 | MP0009697_abnormal_copulation | 2.29170730 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.26683727 |
| 20 | MP0000230_abnormal_systemic_arterial | 2.23923493 |
| 21 | MP0003303_peritoneal_inflammation | 2.22460674 |
| 22 | MP0003252_abnormal_bile_duct | 2.16407585 |
| 23 | MP0000343_altered_response_to | 2.15875491 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.04783333 |
| 25 | MP0009840_abnormal_foam_cell | 2.00931336 |
| 26 | MP0010678_abnormal_skin_adnexa | 1.87272277 |
| 27 | MP0005381_digestive/alimentary_phenotyp | 1.85093734 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.82646478 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.80323657 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.79744578 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.79619278 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.78077848 |
| 33 | MP0000477_abnormal_intestine_morphology | 1.74073683 |
| 34 | MP0005671_abnormal_response_to | 1.69484226 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.68969833 |
| 36 | MP0002796_impaired_skin_barrier | 1.66902542 |
| 37 | MP0005083_abnormal_biliary_tract | 1.66538272 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63782799 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.61537518 |
| 40 | MP0005409_darkened_coat_color | 1.59822114 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.59720963 |
| 42 | MP0005451_abnormal_body_composition | 1.56133683 |
| 43 | MP0004084_abnormal_cardiac_muscle | 1.54425787 |
| 44 | MP0004947_skin_inflammation | 1.50700654 |
| 45 | MP0001663_abnormal_digestive_system | 1.48949111 |
| 46 | MP0003828_pulmonary_edema | 1.48768556 |
| 47 | MP0003879_abnormal_hair_cell | 1.47684970 |
| 48 | MP0002822_catalepsy | 1.45972490 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.44452305 |
| 50 | MP0001879_abnormal_lymphatic_vessel | 1.44057625 |
| 51 | MP0003638_abnormal_response/metabolism_ | 1.43864643 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.43623699 |
| 53 | MP0000249_abnormal_blood_vessel | 1.42233256 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.41809707 |
| 55 | MP0001849_ear_inflammation | 1.41614788 |
| 56 | MP0005365_abnormal_bile_salt | 1.37722788 |
| 57 | MP0002098_abnormal_vibrissa_morphology | 1.33499047 |
| 58 | MP0001664_abnormal_digestion | 1.32210674 |
| 59 | MP0003436_decreased_susceptibility_to | 1.30013878 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.28345576 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.26681966 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.26274454 |
| 63 | MP0005310_abnormal_salivary_gland | 1.24783389 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.22982242 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.22830065 |
| 66 | MP0005410_abnormal_fertilization | 1.20349782 |
| 67 | MP0005023_abnormal_wound_healing | 1.16323276 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.13086299 |
| 69 | MP0003878_abnormal_ear_physiology | 1.13086299 |
| 70 | MP0001873_stomach_inflammation | 1.12640269 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.12197944 |
| 72 | MP0001851_eye_inflammation | 1.10470143 |
| 73 | MP0001800_abnormal_humoral_immune | 1.10364961 |
| 74 | MP0002736_abnormal_nociception_after | 1.09482613 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.08958041 |
| 76 | MP0000490_abnormal_crypts_of | 1.08662123 |
| 77 | MP0006054_spinal_hemorrhage | 1.08331152 |
| 78 | MP0002723_abnormal_immune_serum | 1.08042116 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.07990040 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.07762048 |
| 81 | MP0001790_abnormal_immune_system | 1.07662833 |
| 82 | MP0005387_immune_system_phenotype | 1.07662833 |
| 83 | MP0009763_increased_sensitivity_to | 1.05444258 |
| 84 | MP0002398_abnormal_bone_marrow | 1.05278979 |
| 85 | MP0005165_increased_susceptibility_to | 1.04520341 |
| 86 | MP0005025_abnormal_response_to | 1.03915474 |
| 87 | MP0002452_abnormal_antigen_presenting | 1.03036426 |
| 88 | MP0009642_abnormal_blood_homeostasis | 1.02679496 |
| 89 | MP0000858_altered_metastatic_potential | 1.02134663 |
| 90 | MP0005501_abnormal_skin_physiology | 1.01743153 |
| 91 | MP0001216_abnormal_epidermal_layer | 1.00920105 |
| 92 | MP0009764_decreased_sensitivity_to | 1.00559556 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 1.00483487 |
| 94 | MP0004036_abnormal_muscle_relaxation | 1.00416254 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.98629828 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.98214400 |
| 97 | MP0002254_reproductive_system_inflammat | 0.96793494 |
| 98 | MP0004043_abnormal_pH_regulation | 0.96567178 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.96346439 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.96346439 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.95327896 |
| 102 | MP0002132_abnormal_respiratory_system | 0.94841133 |
| 103 | MP0006138_congestive_heart_failure | 0.94353486 |
| 104 | MP0004147_increased_porphyrin_level | 0.94045097 |
| 105 | MP0003045_fibrosis | 0.93313664 |
| 106 | MP0005367_renal/urinary_system_phenotyp | 0.91131261 |
| 107 | MP0000516_abnormal_urinary_system | 0.91131261 |
| 108 | MP0005187_abnormal_penis_morphology | 0.90201514 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.89669618 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.89062406 |
| 111 | MP0001756_abnormal_urination | 0.87524818 |
| 112 | MP0001501_abnormal_sleep_pattern | 0.87048074 |
| 113 | MP0004130_abnormal_muscle_cell | 0.86702087 |
| 114 | MP0000685_abnormal_immune_system | 0.86392636 |
| 115 | MP0000613_abnormal_salivary_gland | 0.85213397 |
| 116 | MP0000377_abnormal_hair_follicle | 0.84135293 |
| 117 | MP0001819_abnormal_immune_cell | 0.83692969 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.82720590 |
| 119 | MP0002429_abnormal_blood_cell | 0.82601216 |
| 120 | MP0005166_decreased_susceptibility_to | 0.82555778 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.82485666 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.82272294 |
| 123 | MP0000762_abnormal_tongue_morphology | 0.81465717 |
| 124 | MP0004484_altered_response_of | 0.81398184 |
| 125 | MP0002419_abnormal_innate_immunity | 0.81202188 |
| 126 | MP0009780_abnormal_chondrocyte_physiolo | 0.80679558 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.79171175 |
| 128 | MP0009785_altered_susceptibility_to | 0.76454723 |
| 129 | MP0003718_maternal_effect | 0.75309692 |
| 130 | MP0003937_abnormal_limbs/digits/tail_de | 0.74370026 |
| 131 | MP0003329_amyloid_beta_deposits | 0.72962589 |
| 132 | MP0000604_amyloidosis | 0.70361786 |
| 133 | MP0004272_abnormal_basement_membrane | 0.70222117 |
| 134 | MP0005332_abnormal_amino_acid | 0.69168850 |
| 135 | MP0005448_abnormal_energy_balance | 0.63280843 |
| 136 | MP0002060_abnormal_skin_morphology | 0.60879745 |
| 137 | MP0001881_abnormal_mammary_gland | 0.59661438 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.58889507 |
| 139 | MP0000609_abnormal_liver_physiology | 0.56101372 |
| 140 | MP0000470_abnormal_stomach_morphology | 0.55592277 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.55544281 |
| 142 | MP0003938_abnormal_ear_development | 0.53066284 |
| 143 | MP0002896_abnormal_bone_mineralization | 0.51917099 |
| 144 | MP0000579_abnormal_nail_morphology | 0.51565409 |
| 145 | MP0001191_abnormal_skin_condition | 0.49727411 |
| 146 | MP0000163_abnormal_cartilage_morphology | 0.49051991 |
| 147 | MP0004185_abnormal_adipocyte_glucose | 0.48859199 |
| 148 | MP0008872_abnormal_physiological_respon | 0.48472466 |
| 149 | MP0010771_integument_phenotype | 0.47238660 |
| 150 | MP0000627_abnormal_mammary_gland | 0.46307072 |
| 151 | MP0009931_abnormal_skin_appearance | 0.43142267 |
| 152 | MP0003075_altered_response_to | 0.43027231 |
| 153 | MP0004270_analgesia | 0.42814578 |
| 154 | MP0003385_abnormal_body_wall | 0.42177375 |
| 155 | MP0004858_abnormal_nervous_system | 0.41942178 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.40479061 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.40290986 |
| 158 | MP0002148_abnormal_hypersensitivity_rea | 0.38938560 |
| 159 | MP0002932_abnormal_joint_morphology | 0.37242762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.83893780 |
| 2 | Petechiae (HP:0000967) | 9.26627447 |
| 3 | Menorrhagia (HP:0000132) | 8.99346073 |
| 4 | Increased mean platelet volume (HP:0011877) | 8.79635514 |
| 5 | Abnormal platelet volume (HP:0011876) | 8.25636765 |
| 6 | Purpura (HP:0000979) | 7.72422160 |
| 7 | Epistaxis (HP:0000421) | 6.92781360 |
| 8 | Gingival bleeding (HP:0000225) | 6.48624103 |
| 9 | Posterior subcapsular cataract (HP:0007787) | 6.37939398 |
| 10 | Flat acetabular roof (HP:0003180) | 5.77682657 |
| 11 | Abnormality of the 1st metacarpal (HP:0010009) | 5.74221328 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.49051705 |
| 13 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 5.40094693 |
| 14 | Impaired platelet aggregation (HP:0003540) | 5.39170940 |
| 15 | Abnormal platelet function (HP:0011869) | 5.39170940 |
| 16 | Cupped ribs (HP:0000887) | 5.36388091 |
| 17 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 5.16782164 |
| 18 | Fragile nails (HP:0001808) | 4.94089949 |
| 19 | Ileus (HP:0002595) | 4.74911183 |
| 20 | Neonatal short-limb short stature (HP:0008921) | 4.74460537 |
| 21 | Flat capital femoral epiphysis (HP:0003370) | 4.72320166 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 4.62976324 |
| 23 | Spontaneous hematomas (HP:0007420) | 4.60264154 |
| 24 | Poikilocytosis (HP:0004447) | 4.54421648 |
| 25 | Abnormality of carpal bone ossification (HP:0006257) | 4.23795852 |
| 26 | Dyschromatopsia (HP:0007641) | 4.12150663 |
| 27 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 4.04876420 |
| 28 | Irregular epiphyses (HP:0010582) | 4.03056240 |
| 29 | Abnormal pupillary function (HP:0007686) | 4.02079985 |
| 30 | Short phalanx of the thumb (HP:0009660) | 3.96926442 |
| 31 | Abnormality of the 2nd finger (HP:0004100) | 3.96780231 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83286614 |
| 33 | Flattened epiphyses (HP:0003071) | 3.83150248 |
| 34 | Subcapsular cataract (HP:0000523) | 3.74542030 |
| 35 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.71252326 |
| 36 | Short middle phalanx of finger (HP:0005819) | 3.70021612 |
| 37 | Abnormal tarsal ossification (HP:0008369) | 3.66196329 |
| 38 | Onycholysis (HP:0001806) | 3.62103010 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 3.57277821 |
| 40 | Hydroxyprolinuria (HP:0003080) | 3.57277821 |
| 41 | Spinal cord compression (HP:0002176) | 3.53911587 |
| 42 | Breech presentation (HP:0001623) | 3.53900422 |
| 43 | Abnormality of the phalanges of the hallux (HP:0010057) | 3.51317198 |
| 44 | Vertebral clefting (HP:0008428) | 3.51223502 |
| 45 | Abnormal cartilage morphology (HP:0002763) | 3.42359994 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39957365 |
| 47 | Conjunctival telangiectasia (HP:0000524) | 3.37852903 |
| 48 | Breast hypoplasia (HP:0003187) | 3.36137208 |
| 49 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.30879300 |
| 50 | Pustule (HP:0200039) | 3.29265840 |
| 51 | Xanthomatosis (HP:0000991) | 3.21029112 |
| 52 | Short hallux (HP:0010109) | 3.18583352 |
| 53 | Abdominal distention (HP:0003270) | 3.17989386 |
| 54 | Woolly hair (HP:0002224) | 3.14791878 |
| 55 | Abnormal hand bone ossification (HP:0010660) | 3.12578852 |
| 56 | Abnormal ossification of hand bones (HP:0005921) | 3.11906281 |
| 57 | Bruising susceptibility (HP:0000978) | 3.11822243 |
| 58 | Milia (HP:0001056) | 3.10754826 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.03221909 |
| 60 | Aplasia/hypoplasia of the femur (HP:0005613) | 3.02236366 |
| 61 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.01793782 |
| 62 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.98266545 |
| 63 | Vertebral hypoplasia (HP:0008417) | 2.98266545 |
| 64 | Paralysis (HP:0003470) | 2.96194319 |
| 65 | Absent phalangeal crease (HP:0006109) | 2.94805783 |
| 66 | Large earlobe (HP:0009748) | 2.92927094 |
| 67 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.91921591 |
| 68 | Upper limb muscle weakness (HP:0003484) | 2.88323238 |
| 69 | Abnormal auditory evoked potentials (HP:0006958) | 2.87697028 |
| 70 | Joint swelling (HP:0001386) | 2.86360622 |
| 71 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.82012487 |
| 72 | Ridged nail (HP:0001807) | 2.79402390 |
| 73 | Nausea (HP:0002018) | 2.79393839 |
| 74 | Abnormal vertebral ossification (HP:0100569) | 2.77786229 |
| 75 | Hypoplastic ilia (HP:0000946) | 2.76131778 |
| 76 | Chronic diarrhea (HP:0002028) | 2.74905601 |
| 77 | Atrophic scars (HP:0001075) | 2.73561106 |
| 78 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.65658480 |
| 79 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.65556016 |
| 80 | Eczematoid dermatitis (HP:0000976) | 2.64089624 |
| 81 | Conjugated hyperbilirubinemia (HP:0002908) | 2.62880666 |
| 82 | Joint hemorrhage (HP:0005261) | 2.61664858 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.60640759 |
| 84 | Hoarse voice (HP:0001609) | 2.60399081 |
| 85 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.56665958 |
| 86 | Cone-rod dystrophy (HP:0000548) | 2.55975791 |
| 87 | Lumbar hyperlordosis (HP:0002938) | 2.55003194 |
| 88 | Increased density of long bones (HP:0006392) | 2.51227765 |
| 89 | Shawl scrotum (HP:0000049) | 2.50727577 |
| 90 | Abnormal foot bone ossification (HP:0010675) | 2.50696590 |
| 91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.45758989 |
| 92 | Malnutrition (HP:0004395) | 2.44424368 |
| 93 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.43185418 |
| 94 | Abnormality of femoral epiphyses (HP:0006499) | 2.43185418 |
| 95 | Short tibia (HP:0005736) | 2.43014026 |
| 96 | Decreased central vision (HP:0007663) | 2.42340387 |
| 97 | Tracheal stenosis (HP:0002777) | 2.41020696 |
| 98 | Abnormal finger flexion creases (HP:0006143) | 2.40135061 |
| 99 | Pterygium (HP:0001059) | 2.38828646 |
| 100 | Increased IgM level (HP:0003496) | 2.38469987 |
| 101 | Hyperglycinuria (HP:0003108) | 2.38224462 |
| 102 | Abnormality of the femoral head (HP:0003368) | 2.37256374 |
| 103 | Tongue fasciculations (HP:0001308) | 2.35287242 |
| 104 | Relative macrocephaly (HP:0004482) | 2.34634083 |
| 105 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33021038 |
| 106 | Goiter (HP:0000853) | 2.32840413 |
| 107 | Metabolic alkalosis (HP:0200114) | 2.31507801 |
| 108 | Short humerus (HP:0005792) | 2.30822241 |
| 109 | Plantar hyperkeratosis (HP:0007556) | 2.30255425 |
| 110 | Flared iliac wings (HP:0002869) | 2.26116822 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.25935939 |
| 112 | Hip contracture (HP:0003273) | 2.25925105 |
| 113 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.25027704 |
| 114 | Muscle fibrillation (HP:0010546) | 2.24904415 |
| 115 | Spontaneous abortion (HP:0005268) | 2.24146850 |
| 116 | Proximal placement of thumb (HP:0009623) | 2.24100926 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.20183605 |
| 118 | Polar cataract (HP:0010696) | 2.19990418 |
| 119 | Pili torti (HP:0003777) | 2.19945077 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 2.18775459 |
| 121 | Acanthocytosis (HP:0001927) | 2.18120248 |
| 122 | Coronal craniosynostosis (HP:0004440) | 2.16340963 |
| 123 | Visceral angiomatosis (HP:0100761) | 2.15269709 |
| 124 | Deviation of the thumb (HP:0009603) | 2.14785195 |
| 125 | Biliary tract neoplasm (HP:0100574) | 2.14266906 |
| 126 | Ventricular fibrillation (HP:0001663) | 2.13393389 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 2.11647637 |
| 128 | Tinnitus (HP:0000360) | 2.10896178 |
| 129 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.09874965 |
| 130 | Hip dysplasia (HP:0001385) | 2.08951152 |
| 131 | Abnormality of lateral ventricle (HP:0030047) | 2.07755056 |
| 132 | Dehydration (HP:0001944) | 2.07489972 |
| 133 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.07037354 |
| 134 | Hypobetalipoproteinemia (HP:0003563) | 2.04170013 |
| 135 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03179708 |
| 136 | Decreased circulating renin level (HP:0003351) | 2.02131505 |
| 137 | Polycythemia (HP:0001901) | 2.01739780 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00466165 |
| 139 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.98916799 |
| 140 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96881701 |
| 141 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.96454409 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.95887276 |
| 143 | Progressive sensorineural hearing impairment (HP:0000408) | 1.95585234 |
| 144 | Systemic lupus erythematosus (HP:0002725) | 1.94821679 |
| 145 | Hyperphosphaturia (HP:0003109) | 1.94228898 |
| 146 | Hemangiomatosis (HP:0007461) | 1.94061138 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.93137664 |
| 148 | High anterior hairline (HP:0009890) | 1.91673624 |
| 149 | Ureteral stenosis (HP:0000071) | 1.91483189 |
| 150 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88665064 |
| 151 | Encephalitis (HP:0002383) | 1.88625126 |
| 152 | Arterial thrombosis (HP:0004420) | 1.82186798 |
| 153 | Male infertility (HP:0003251) | 1.81418631 |
| 154 | Stomatitis (HP:0010280) | 1.77972439 |
| 155 | Hemorrhage of the eye (HP:0011885) | 1.77943691 |
| 156 | Papillary thyroid carcinoma (HP:0002895) | 1.77844550 |
| 157 | Myocardial infarction (HP:0001658) | 1.76648936 |
| 158 | Abnormality of the prostate (HP:0008775) | 1.71733650 |
| 159 | Polyphagia (HP:0002591) | 1.70987102 |
| 160 | Abnormality of renin-angiotensin system (HP:0000847) | 1.67967352 |
| 161 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.67526426 |
| 162 | Hypophosphatemic rickets (HP:0004912) | 1.67520393 |
| 163 | Cerebral hemorrhage (HP:0001342) | 1.64705130 |
| 164 | Alkalosis (HP:0001948) | 1.63047519 |
| 165 | Testicular neoplasm (HP:0010788) | 1.62900773 |
| 166 | Vascular calcification (HP:0004934) | 1.61494109 |
| 167 | Growth hormone excess (HP:0000845) | 1.59363080 |
| 168 | Chest pain (HP:0100749) | 1.58914585 |
| 169 | Neoplasm of the rectum (HP:0100743) | 1.56622498 |
| 170 | Basal ganglia calcification (HP:0002135) | 1.56559902 |
| 171 | Thyroid-stimulating hormone excess (HP:0002925) | 1.55275633 |
| 172 | Inflammation of the large intestine (HP:0002037) | 1.54778411 |
| 173 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.53811090 |
| 174 | Back pain (HP:0003418) | 1.53807773 |
| 175 | Thrombocytosis (HP:0001894) | 1.53700940 |
| 176 | Renal tubular acidosis (HP:0001947) | 1.52987034 |
| 177 | Increased serum ferritin (HP:0003281) | 1.52985975 |
| 178 | Chronic obstructive pulmonary disease (HP:0006510) | 1.52792866 |
| 179 | Obstructive lung disease (HP:0006536) | 1.52792866 |
| 180 | Insidious onset (HP:0003587) | 1.52435805 |
| 181 | Termporal pattern (HP:0011008) | 1.52435805 |
| 182 | Episodic fever (HP:0001954) | 1.52361911 |
| 183 | Vertigo (HP:0002321) | 1.49452821 |
| 184 | Abnormality of magnesium homeostasis (HP:0004921) | 1.48151462 |
| 185 | Mitral stenosis (HP:0001718) | 1.46975630 |
| 186 | Tetraparesis (HP:0002273) | 1.45754982 |
| 187 | Leiomyosarcoma (HP:0100243) | 1.45673531 |
| 188 | Uterine leiomyosarcoma (HP:0002891) | 1.45673531 |
| 189 | Gastrointestinal dysmotility (HP:0002579) | 1.43400022 |
| 190 | Cardiovascular calcification (HP:0011915) | 1.42012772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 4.87605038 |
| 2 | ACVR1B | 3.25672520 |
| 3 | FRK | 3.00771352 |
| 4 | MST1R | 2.88054298 |
| 5 | RIPK1 | 2.86553080 |
| 6 | TEC | 2.70388199 |
| 7 | BTK | 2.65978687 |
| 8 | MST4 | 2.65833722 |
| 9 | PIK3CG | 2.26821782 |
| 10 | EPHA2 | 2.24754172 |
| 11 | EIF2AK1 | 2.23415421 |
| 12 | CSF1R | 2.12043938 |
| 13 | MAP2K2 | 2.05611743 |
| 14 | SYK | 2.04549613 |
| 15 | TAOK3 | 12.8161096 |
| 16 | GRK5 | 1.88444543 |
| 17 | MAP3K9 | 1.86095935 |
| 18 | ZAP70 | 1.81168845 |
| 19 | GRK6 | 1.80868718 |
| 20 | KSR2 | 1.78175576 |
| 21 | TAOK1 | 1.70825438 |
| 22 | STK24 | 1.66773488 |
| 23 | NME1 | 1.63196699 |
| 24 | PTK6 | 1.58926072 |
| 25 | EPHA3 | 1.54344507 |
| 26 | PIK3CA | 1.49955569 |
| 27 | LMTK2 | 1.47180645 |
| 28 | MAP3K13 | 1.42098113 |
| 29 | PRKG2 | 1.38617634 |
| 30 | TNIK | 1.35346919 |
| 31 | HCK | 1.31819235 |
| 32 | ARAF | 1.29121650 |
| 33 | MAP3K2 | 1.22809614 |
| 34 | BLK | 1.21136299 |
| 35 | PTK2 | 1.20211518 |
| 36 | MAPKAPK3 | 1.16483602 |
| 37 | LYN | 1.14695768 |
| 38 | ICK | 1.08592496 |
| 39 | IRAK1 | 1.08100472 |
| 40 | DAPK2 | 1.02918997 |
| 41 | DAPK3 | 0.99949907 |
| 42 | ADRBK2 | 0.99391431 |
| 43 | MAP2K1 | 0.98469009 |
| 44 | RIPK4 | 0.96639095 |
| 45 | TESK1 | 0.95708450 |
| 46 | MAP3K14 | 0.93920167 |
| 47 | ERN1 | 0.90375709 |
| 48 | FES | 0.89473052 |
| 49 | MET | 0.87610892 |
| 50 | RET | 0.87062506 |
| 51 | KDR | 0.86387059 |
| 52 | IKBKB | 0.85251020 |
| 53 | AKT3 | 0.82969559 |
| 54 | MAP3K5 | 0.82648828 |
| 55 | TXK | 0.80062814 |
| 56 | SIK3 | 0.78034003 |
| 57 | PRKCI | 0.73792092 |
| 58 | PDGFRB | 0.73556021 |
| 59 | EPHB1 | 0.70507424 |
| 60 | TNK2 | 0.66823667 |
| 61 | PRKD1 | 0.66816078 |
| 62 | MAP2K3 | 0.66257523 |
| 63 | MAP3K12 | 0.65156382 |
| 64 | STK39 | 0.64704998 |
| 65 | TTK | 0.63598580 |
| 66 | NLK | 0.61895280 |
| 67 | TRIM28 | 0.61448261 |
| 68 | ADRBK1 | 0.60962864 |
| 69 | ERBB2 | 0.60261962 |
| 70 | YES1 | 0.58792926 |
| 71 | JAK1 | 0.58339506 |
| 72 | PLK2 | 0.57746391 |
| 73 | PAK4 | 0.57123340 |
| 74 | STK10 | 0.56440299 |
| 75 | MAP3K8 | 0.55958372 |
| 76 | TLK1 | 0.53546079 |
| 77 | MYLK | 0.53445822 |
| 78 | FER | 0.52698746 |
| 79 | IRAK3 | 0.51800996 |
| 80 | TAOK2 | 0.50083622 |
| 81 | MOS | 0.49333230 |
| 82 | ERBB4 | 0.48780080 |
| 83 | FYN | 0.48373507 |
| 84 | MATK | 0.48343011 |
| 85 | LCK | 0.47745712 |
| 86 | PNCK | 0.47446003 |
| 87 | AURKB | 0.47314709 |
| 88 | MAP3K1 | 0.47184147 |
| 89 | DAPK1 | 0.46915374 |
| 90 | STK4 | 0.44389244 |
| 91 | MAP3K3 | 0.43896875 |
| 92 | MAP3K10 | 0.41977226 |
| 93 | KSR1 | 0.41249522 |
| 94 | MAPK11 | 0.41076821 |
| 95 | JAK3 | 0.40884286 |
| 96 | DMPK | 0.40422911 |
| 97 | TESK2 | 0.39771025 |
| 98 | PAK1 | 0.38703177 |
| 99 | PRKAA2 | 0.38375434 |
| 100 | MAP2K6 | 0.38178547 |
| 101 | PRKG1 | 0.37547965 |
| 102 | PTK2B | 0.36688928 |
| 103 | LIMK1 | 0.36438726 |
| 104 | CAMK2D | 0.36332356 |
| 105 | NUAK1 | 0.35266167 |
| 106 | MINK1 | 0.34805721 |
| 107 | LATS1 | 0.34715564 |
| 108 | DDR2 | 0.34708101 |
| 109 | MAP4K1 | 0.34242156 |
| 110 | IGF1R | 0.33804904 |
| 111 | BMX | 0.33717065 |
| 112 | BRAF | 0.32212347 |
| 113 | MARK3 | 0.31957978 |
| 114 | ILK | 0.31512671 |
| 115 | SRC | 0.31410884 |
| 116 | PIM1 | 0.30645291 |
| 117 | MELK | 0.30569641 |
| 118 | PDPK1 | 0.29719957 |
| 119 | PKN1 | 0.29527286 |
| 120 | PRKCB | 0.29356148 |
| 121 | ITK | 0.26981446 |
| 122 | TYK2 | 0.24057641 |
| 123 | PRKCQ | 0.23237662 |
| 124 | PAK3 | 0.23068071 |
| 125 | PDK1 | 0.22063939 |
| 126 | PRKCA | 0.21655952 |
| 127 | STK11 | 0.20981106 |
| 128 | CAMK2B | 0.20894397 |
| 129 | BMPR2 | 0.20669030 |
| 130 | RAF1 | 0.20186990 |
| 131 | CAMK2G | 0.19734780 |
| 132 | CSK | 0.16534888 |
| 133 | FGFR1 | 0.14133493 |
| 134 | LATS2 | 0.12457314 |
| 135 | PRKAA1 | 0.12431172 |
| 136 | FGR | 0.10562721 |
| 137 | MAP3K7 | 0.09299034 |
| 138 | AKT2 | 0.09120020 |
| 139 | LRRK2 | 0.08766756 |
| 140 | DYRK2 | 0.08532671 |
| 141 | FGFR4 | 0.07036210 |
| 142 | ABL2 | 0.05108239 |
| 143 | GRK1 | 0.05002282 |
| 144 | PIM2 | 0.04838808 |
| 145 | PRKD2 | 0.04313157 |
| 146 | CDK7 | 0.04126895 |
| 147 | PDK2 | 0.03702108 |
| 148 | CAMK2A | 0.03122147 |
| 149 | PRKACG | 0.02525548 |
| 150 | TBK1 | 0.02165011 |
| 151 | RPS6KA1 | 0.01839862 |
| 152 | JAK2 | 0.01731460 |
| 153 | MAPKAPK2 | 0.01581403 |
| 154 | EEF2K | 0.01556522 |
| 155 | PRKCD | 0.01346589 |
| 156 | STK3 | 0.00705209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.54377171 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.33183592 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.29807335 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 4.22045003 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 4.02361305 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.73617274 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.97581007 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.70919411 |
| 9 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.56818138 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47327973 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 2.37435145 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.29628786 |
| 13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.21665173 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.13867187 |
| 15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.03914296 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.89297647 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.88953099 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82815619 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62711146 |
| 20 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.61315456 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48964333 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47818074 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45097949 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.42223853 |
| 25 | Gap junction_Homo sapiens_hsa04540 | 1.39262160 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32261146 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31529656 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22017194 |
| 29 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.19455665 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17917253 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16387840 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15351008 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15269942 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15248530 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14034966 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13610259 |
| 37 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.12624983 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11420442 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09702351 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.08921292 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.07955046 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04362162 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02936944 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98247012 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98218614 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97888247 |
| 47 | Endocytosis_Homo sapiens_hsa04144 | 0.94558120 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93344603 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93192065 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92217420 |
| 51 | Alcoholism_Homo sapiens_hsa05034 | 0.91046482 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.90734778 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89627850 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88981152 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86959859 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.86120172 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83678008 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80431955 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78424882 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78030317 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77999584 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77688434 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76572294 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75236911 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75011689 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.73451529 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.72831865 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71351577 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70834293 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69242761 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69086748 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65128825 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.64481418 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.64384161 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63262756 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62913241 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62844035 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.61217493 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61208186 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59875748 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.58223412 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58214136 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57456623 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57209518 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57117799 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56595747 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55214627 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.54557957 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54317997 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53865114 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53552076 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53161347 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52495803 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51277465 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50697486 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50629068 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.50584976 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50568674 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.49964063 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.49718648 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49194735 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47832053 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47666584 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47179664 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.46643370 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46384134 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.45803889 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45779699 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45552701 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45424155 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44910214 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44042172 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43706318 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43590386 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43537478 |
| 116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43283986 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41702507 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41021167 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40330580 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40215697 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39843549 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39723298 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39156195 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37737634 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37541277 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35930255 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34168297 |
| 128 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32936754 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32553679 |
| 130 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31648980 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.29328086 |
| 132 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.28792499 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28202567 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27862408 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26103445 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25779448 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25609629 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.24620123 |
| 139 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24195469 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23064932 |
| 141 | Influenza A_Homo sapiens_hsa05164 | 0.22567913 |
| 142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19080934 |
| 143 | Leishmaniasis_Homo sapiens_hsa05140 | 0.18260176 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17705555 |
| 145 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17498031 |
| 146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15275282 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14337394 |
| 148 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.13871616 |

